Corbus Pharmaceuticals Inc.
10 clinical trials · Sponsor
◉ Watch Corbus Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| A Randomized, Multicentre, Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma (NCT07768189) | Corbus Pharmaceuticals Inc. | 2026-09-20 |
| A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity (NCT07310901) | Corbus Pharmaceuticals Inc. | 2025-12-04 |
| First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. (NCT06603844) | Corbus Pharmaceuticals Inc. | 2024-12-04 |
| A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors (NCT06265727) | Corbus Pharmaceuticals Inc. | 2024-04-01 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis (NCT03813160) | Corbus Pharmaceuticals Inc. | 2018-12-17 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis (NCT03451045) | Corbus Pharmaceuticals Inc. | 2017-12-22 |
Track Corbus Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.